MRSA | MSSA colonization risk mitigation solutions
The COVID-19 pandemic has caused a diversion of resources, increasing the risk of HAIs. During this time, hospitals were challenged to rethink protocols to enhance the safety of patients and staff.
THE PRESENTERS
John Willimann
CEO & Co-founder, Nozin
Sue Barnes, RN, CIC, FAPIC
IP Clinical Consultant
The COVID-19 pandemic has led to the increased adoption of innovative technology in many hospitals to help ensure the safety of patients and staff.
During this webinar, medical experts will inform attendees of the importance of nasal sanitization – a proven infection prevention measure used by hospitals that can be applied to the workplace setting as well.
Making a difference in patient care.
Anita Mullen
RN, BSN, Infection Preventionist
Better Care. Lower Costs.
Reducing Infection Risk through Antiseptic-based Nasal Decolonization
Maureen Spencer
RN, M.Ed., CIC, FAPIC
Evidence shows nasal bacteria are a primary component in the spread of infection. Nozin® Nasal Sanitizer® antiseptic can help reduce the risk without antibiotics, improve quality of care & lower costs.
%
%
%
%
Phone:
877-669-4648
301-337-2059
Mail:
Nozin
P.O. Box 70663
Chevy Chase, MD 20813
